309 related articles for article (PubMed ID: 26609227)
1. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
3. Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
Wu YQ; Shen YC; Wang H; Zhang JL; Li DD; Zhang X; Wang T; Xu D; Ying BW; Wang LL; Wen FQ
Eur Rev Med Pharmacol Sci; 2016; 20(1):44-53. PubMed ID: 26813452
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
8. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
9. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
10. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
11. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
12. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.
Hattori K; Ishii T; Motegi T; Kusunoki Y; Gemma A; Kida K
Int J Chron Obstruct Pulmon Dis; 2015; 10():309-20. PubMed ID: 25709425
[TBL] [Abstract][Full Text] [Related]
15. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
[TBL] [Abstract][Full Text] [Related]
16. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.
Urban MH; Eickhoff P; Funk GC; Burghuber OC; Wolzt M; Valipour A
Int J Chron Obstruct Pulmon Dis; 2017; 12():169-176. PubMed ID: 28115840
[TBL] [Abstract][Full Text] [Related]
17. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke.
Pan X; Pang M; Ma A; Wang K; Zhang Z; Zhong Q; Yang S
PLoS One; 2015; 10(9):e0136414. PubMed ID: 26334877
[TBL] [Abstract][Full Text] [Related]
18. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
[TBL] [Abstract][Full Text] [Related]
19. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
